Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could talk therapy ease the burden of migraine for veterans?

NCT ID NCT07792291

Symptom relief Sponsor: Yale University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Sep 01, 2026 · Updated 2 times

Summary

Researchers at Yale University are testing whether cognitive behavioral therapy for migraine (CBTm) can improve quality of life for veterans with episodic migraine. The study compares CBTm, a six-session behavioral program, to a digital migraine education intervention. Participants are veterans with a migraine diagnosis who report 4 to 14 headache days per month. The trial focuses on whether the therapy is feasible and whether it helps reduce migraine-related disability.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cognitive behavioral therapy for migraine (CBTm) compared with a digital migraine education intervention
What this could lead to
If it works, this could point toward a practical, non-drug way to ease migraine-related disability and improve quality of life for veterans.
What could go wrong
This is a small early feasibility study with 24 participants, so results may not apply broadly. CBT requires time and effort, and not everyone may benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Physician diagnosis of migraine * Fluent in English * Capacity to consent * Currently meets International Classification of Headache Disorders-3 (ICHD-3) migraine criteria * Self-report 4-14 monthly headache days in past 28 days * Score of at least moderate disability (≥ 10) on the MIDAS Exclusion Criteria: * Secondary headache only * Currently meets criteria for a Trigeminal Autonomic Cephalalgia * Self-report \< 4 or \>14 headache days in past 28 days * Utilization of behavioral treatments for migraine or pain in the past 12 months * Score of less than 10 on the MIDAS * Reports active suicidal ideation (endorses Ideation items 3, 4 or 5, or any Suicidal Behavior items in the past 12 months * Has a pending disability or service connection claim related to migraine or headache disorders

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Episodic migraine headache are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Episodic migraine headache Migraine Migraine headache

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • VA Connecticut Healthcare System

    West Haven, Connecticut, 06516, United States

  • VA South Texas Healthcare System

    San Antonio, Texas, 78224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.